Quest LaboratoriesNSE:QUESTLAB +1.28%52 12-1 Month Momentum % is 3.38% as of Jul. 06, 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 52/100. The stock has 7 warning signs investors should review. Among 1,022 Drug Manufacturers companies, Quest Laboratories ranks better than 65.36% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-06), Quest Laboratories's 12-1 Month Momentum % is 3.38%.
The industry rank for Quest Laboratories's 12-1 Month Momentum % or its related term are showing as below:
NSE:QUESTLAB's 12-1 Month Momentum % is ranked better than 65.36% of 1022
companies
in the Drug Manufacturers industry
Industry Median: -10.205
vs NSE:QUESTLAB: 3.38
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Quest Laboratories 12-1 Month Momentum % Related Terms
NSE:QUESTLAB vs LLY, JNJ, ABBV: 12-1 Month Momentum % Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories 12-1 Month Momentum % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories (NSE:QUESTLAB) has a 12-1 Month Momentum % of 3.38% as of Jul. 06, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Quest Laboratories and its competitors. According to the industry distribution chart, Quest Laboratories ranks #354 out of 1022 companies in the Drug Manufacturers industry, placing it in the top 34.6%.
Is Quest Laboratories' 12-1 Month Momentum % too high?
Quest Laboratories' current 12-1 Month Momentum % is 3.38%. Based on the distribution chart, Quest Laboratories ranks #354 out of 1022 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Quest Laboratories has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' 12-1 Month Momentum % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #354 out of 1022 companies for 12-1 Month Momentum %. This puts Quest Laboratories in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Drug Manufacturers company?
A good 12-1 Month Momentum % depends on the Drug Manufacturers industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Quest Laboratories and its competitors. Quest Laboratories's current 12-1 Month Momentum % is 3.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current 12-1 Month Momentum % of 3.38%. The current 12-1 Month Momentum % is 3.38%. Quest Laboratories' overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current 12-1 Month Momentum % is 3.38% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
52GF Score
Get the complete analysis for NSE:QUESTLAB
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 